Order:
Careers Media center Contacts

AMOXIL-K




Active substance: аmoxicillin and enzyme inhibitor

ATC: J01CR02

How supplied: Powder for injection

Dosage form
Powder for injection №1 intravenous adm.

Active ingredient
1 vial contains sterile mixture (5:1) of amoxicillin sodium and clavulanate potassium salt, calculated on the amoxicillin 1.0 g and clavulanic acid 0.2 g.

INDICATIONS
Treatment of bacterial infections caused by susceptible to the Amoxil-K microorganisms, such as severe infections of the throat, nose and ear (mastoiditis, peritonsillar infections, epiglottitis, and sinusitis associated with severe systemic signs and symptoms); exacerbation of chronic bronchitis (after confirmation of the  diagnosis); community-acquired pneumonia; cystitis; pyelonephritis; infections of the skin and soft tissues, including bacterial cellulitis, animal bites, severe dentoalveolar abscesses with cellulitis spread; bone and joint infections, including osteomyelitis; intra-abdominal infections; genital infections in women. Prevention of bacterial infections in major surgery in the following areas: gastrointestinal tract; pelvic organs; head and neck; biliary tract.

ATTENTION!

The following information is intended for medical and pharmaceutical professionals only and can be used exclusively in professional activities.

ARE YOU A MEDICAL AND/OR PHARMACEUTICAL PROFESSIONAL?

(submitting the answer, you bear full responsibility for the accuracy of the information provided)


The presented package image matches the product design registered with the Ukrainian regulatory authorities.

If you have noticed any differences, please call us at +380 44 490 75 22

PHARMACOVIGILANCE

If you have information about any adverse effects or other drug-related problems, please fill in the form